SPX3,998.84-72.86 -1.79%
DIA340.03-4.71 -1.37%
IXIC11,239.94-221.56 -1.93%

BRIEF-Simcere Pharmaceutical Announces Exclusive License Deal With Idorsia For Insomnia Drug

Reuters · 11/15/2022 20:25
BRIEF-Simcere Pharmaceutical Announces Exclusive License Deal With Idorsia For Insomnia Drug

- Simcere Pharmaceutical Group Ltd 2096.HK:

  • EXCLUSIVE LICENSE AGREEMENT WITH IDORSIA FOR INSOMNIA DRUG DARIDOREXANT

  • UNDER DEAL, GROUP TO BE GRANTED EXCLUSIVE RIGHT TO DEVELOP AND COMMERCIALIZE INSOMNIA DRUG DARIDOREXANT IN GREATER CHINA

  • UNDER AGREEMENT, IDORSIA WILL RECEIVE A US$30 MILLION UPFRONT PAYMENT

  • UNDER DEAL, ELIGIBLE TO RECEIVE ADDITIONAL MILESTONE PAYMENT OF US$20 MILLION UPON REGULATORY APPROVAL BY CHINA NMPA

Further company coverage: 2096.HK


((Reuters.Briefs@thomsonreuters.com;))